GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Current Liabilities | - | - | - | - | - |
What is the latest Current Liabilities ratio of GLENMARK PHARMACEUTICALS ?
Year | Current Liabilities |
---|---|
Mar2024 | - |
Mar2023 | - |
Mar2022 | - |
Mar2021 | - |
Mar2020 | - |
How is Current Liabilities of GLENMARK PHARMACEUTICALS Trending?
Years | Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | - | 0 | |
Mar2023 | - | 0 | |
Mar2022 | - | 0 | |
Mar2021 | - | 0 | |
Mar2020 | - | - |
Compare Current Liabilities of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹58,529.7 Cr | -3.8% | 13.2% | 43.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹393,731.0 Cr | -4.1% | -2.1% | -5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹172,373.0 Cr | -2.8% | -5.9% | 29.2% | Stock Analytics | |
CIPLA | ₹122,411.0 Cr | -3.7% | 0.1% | -2.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,285.0 Cr | -4.1% | 7.3% | 14.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,270.0 Cr | -5.7% | -6.1% | -11.6% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | -3.8% |
13.2% |
43.7% |
SENSEX | 0.2% |
-2.7% |
-0.9% |
You may also like the below Video Courses